Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Gregory L. Weaver currently holds 28,078 shares of Eloxx Pharmaceuticals, Inc. (ELOX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Gregory L. Weaver has been a net seller of ELOX stock. They have purchased $423.0K and sold $671.8K worth of shares.
Gregory L. Weaver's most recent insider trade was on Mar 6, 2026, when they purchased 5,000 shares at $3.54 per share.
Gregory L. Weaver serves as Executive at Eloxx Pharmaceuticals, Inc. (ELOX). They have executed 38 insider transactions totaling $1.1M over their tenure at the company.
Gregory L. Weaver holds the position of Executive at Eloxx Pharmaceuticals, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Gregory L. Weaver has shown a selling trading pattern, with $423.0K in total purchases and $671.8K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Gregory L. Weaver was on Jul 2, 2021, when they sold $599.8K worth of ATOS shares. This transaction involved 107,497 shares at $5.58 per share.
Gregory L. Weaver currently owns 28,078 shares of Eloxx Pharmaceuticals, Inc. (ELOX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Gregory L. Weaver's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Gregory L. Weaver has 38 Form 4 filings on record as an insider at Eloxx Pharmaceuticals, Inc..
Set alerts for Gregory L. Weaver and 40,000+ other insiders.